+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Disorder of lipid metabolism

Lipid metabolism disorder refers to a group of conditions characterized by abnormalities in the synthesis, transport, or degradation of lipids (fats) in the body. These disorders can lead to elevated or reduced levels of cholesterol, triglycerides, or lipoproteins, increasing the risk of cardiovascular diseases, pancreatitis, and other systemic complications. They can be primary (genetic) or secondary (due to lifestyle, diet, or other medical conditions).
Catalog No Product Description CAS No. Purity Structural Formula
BP2026
Baicalin methyl ester
Baicalin methyl ester shows inhibitory effects on the Avian Myeloblastosis Virus reverse transcriptase (AMV-RT).
82475-03-4 95% Baicalin methyl ester
BP0237
Beta-Sitosterol
Sitosterol is a member of the class of phytosterols that is stigmast-5-ene substituted by a beta-hydroxy group at position 3. It has a role as an antioxidant, an anticholesteremic drug, a sterol methyltransferase inhibitor, a mouse metabolite and a plant metabolite. It is a stigmastane sterol, a 3beta-hydroxy-Delta(5)-steroid, a C29-steroid, a member of phytosterols and a 3beta-sterol. It derives from a hydride of a stigmastane.
83-46-5 98% Beta-Sitosterol
BP0042 112246-15-8 98% 20(R)-Ginsenoside Rh2